Last reviewed · How we verify

mammalian Omega 3 Fatty acids

McGill University Health Centre/Research Institute of the McGill University Health Centre · Phase 3 active Small molecule

Mammalian Omega 3 Fatty acids work by reducing inflammation and improving cardiovascular health through their effects on the body's fatty acid metabolism.

Mammalian Omega 3 Fatty acids work by reducing inflammation and improving cardiovascular health through their effects on the body's fatty acid metabolism. Used for Hypertriglyceridemia, Cardiovascular disease.

At a glance

Generic namemammalian Omega 3 Fatty acids
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre
Drug classFatty acid
ModalitySmall molecule
Therapeutic areaCardiovascular
PhasePhase 3

Mechanism of action

They do this by influencing the production of eicosanoids, which are hormone-like substances that promote inflammation. Omega 3 Fatty acids also have anti-inflammatory effects on the body's immune system, which can help to reduce the risk of cardiovascular disease.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: